MYRA VISION
Myra Vision designs a treatment that allows maximum IOP reduction for patients with moderate to severe glaucoma. It is a privately held portfolio company of Shifamed LLC. The company accelerates its development of the first-of-its-kind treatment for patients with moderate to severe glaucoma through its latest funding.
MYRA VISION
Industry:
Health Care Medical Medical Device Wellness
Founded:
2016-03-23
Address:
Campbell, California, United States
Country:
United States
Website Url:
http://www.myravision.com
Total Employee:
1+
Status:
Active
Contact:
4085602500
Total Funding:
25.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Global Site Tag
Similar Organizations
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Current Advisors List
Board_member
Current Employees Featured
Robert Chang President, CEO @ Myra Vision
President, CEO
Founder
Investors List
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Myra Vision
The Capital Partnership
The Capital Partnership investment in Series A - Myra Vision
Official Site Inspections
http://www.myravision.com
- Host name: 84.120.174.34.bc.googleusercontent.com
- IP address: 34.174.120.84
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Myra Vision"
Myra Medical
Mar 3, 2025 Myra Vision is a dynamic organization committed to bringing personalized glaucoma care to the surgical armamentarium by delivering an adjustable solution for patients who are …See details»
Myra Vision - LinkedIn
Myra Vision | 1,402 followers on LinkedIn. a Shifamed Portfolio Company | Myra Vision, a privately held portfolio company of Shifamed LLC, is developing a novel technology that is designed to ...See details»
Myra Vision - Crunchbase Company Profile & Funding
Organization. Myra Vision . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email info@myravision.com; Phone Number …See details»
Myra Vision 2025 Company Profile: Valuation, Funding ... - PitchBook
Myra Vision General Information Description. Developer of surgical techniques designed to improve treatment for glaucoma patients. The company's novel technology allows intraocular …See details»
Myra Vision Announces Positive Initial Outcomes from its …
Mar 3, 2025 Myra Vision, a privately held portfolio company of Shifamed LLC, is developing a new aqueous shunt that is designed to allow safe personalized IOP control, based on the …See details»
Myra Vision - Company Profile - Tracxn
Feb 12, 2025 Email ID: *****@myravision.com; Key Metrics. Total Funding. $42M in 2 rounds. Latest Funding Round. Series B, Jun 26, 2023, $25M. Investors. The Capital Partnership & 6 …See details»
Myra Vision, a Shifamed Portfolio Company, Closes $25M in Series …
Jun 26, 2023 Myra Vision, a privately held portfolio company of Shifamed LLC, is developing a novel technology that is designed to allow safe outflow control to achieve maximum reduction …See details»
Myra Vision - Overview, News & Similar companies - ZoomInfo
May 1, 2024 Myra Vision contact info: Phone number: (408) 560-2500 Website: www.myravision.com What does Myra Vision do? Myra Vision is advancing surgical devices to …See details»
Myra Vision Summary - Craft
Myra Vision has 5 employees at their 1 location and $20.16 m in total funding,. See insights on Myra Vision including office locations, competitors, revenue, financials, executives, …See details»
Myra Vision - Products, Competitors, Financials, Employees ...
To learn more about Myra Vision, please visit www.myravision.com . About Shifamed, LLC. Founded by serial entrepreneur Amr Salahieh, Shifamed LLC is a highly specialized medical …See details»
MedTech Strategist - Myra Vision Personalizes Glaucoma Care
Dec 12, 2024 Myra Vision, part of the prolific Shifamed innovation hub in Campbell, CA, wants to evolve glaucoma treatment with an adjustable implanted device.The company’s CEO, Robert …See details»
Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series …
Jun 1, 2021 Myra Vision, a privately held portfolio company of Shifamed LLC, is developing a novel technology that is designed to allow safe outflow control to achieve maximum intraocular …See details»
MyraVision’s Calibreye™ Titratable Glaucoma Therapy ... - Shifamed
May 1, 2024 MyraVision’s Calibreye™ Titratable Glaucoma Therapy™ Surgical System Showcased At Ophthalmology Conferences Receiving Best Paper Award And Recognition Of …See details»
MYRA VISION'S CALIBREYE™ TITRATABLE GLAUCOMA THERAPY™ …
CAMPBELL, Calif., May 1, 2024 /PRNewswire/ -- Myra Vision, a Shifamed portfolio company, announced today its Calibreye™ Titratable Glaucoma Therapy™ (TGT) Surgical System, a …See details»
Myra Vision Announces Positive Initial Outcomes from its
Mar 4, 2025 Myra Vision, a privately held portfolio company of Shifamed LLC, is developing a new aqueous shunt that is designed to allow safe personalized IOP control, based on the …See details»
Titratable Outflow - Myra Medical - myravision.com
OUTFLOW CHANNELS. The Calibreye Shunt has 3 distinct outflow channels. The standard channel is open in all settings. The medium channel and large channel are valve controlled.See details»
Myra Vision Announces Successful First-In-Human Use of its …
Sep 6, 2023 Myra Vision, a privately held portfolio company of Shifamed LLC, is developing a novel technology that is designed to allow safe outflow control to achieve maximum reduction …See details»
Myra Vision Announces Positive Initial Outcomes from its …
Mar 3, 2025 The multi-center international study enrolled 43 patients with moderate to late-stage disease, of which 33 patients had greater than 3 months of follow-up, at four sites in three …See details»
Myra Vision, A Shifamed Portfolio Company, Closes $17M In Series …
CAMPBELL, Calif., June 1, 2021 /PRNewswire/ -- Myra Vision, a Shifamed portfolio company, announced today the closing of its $17M Series A financings, which will be used to advance …See details»
MYRA VISION, A SHIFAMED PORTFOLIO COMPANY, CLOSES …
Jun 26, 2023 Glaucoma, a leading cause of blindness, affects an estimated 66M people worldwide. 1 More than one third of patients have moderate to advanced glaucoma, which …See details»